Exponent Inc (EXPO)

Total asset turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 558,514 544,648 541,705 541,390 536,766 541,221 535,064 525,124 513,293 499,444 488,670 478,266 466,269 456,002 438,260 410,428 399,900 406,775 409,660 424,121
Total assets US$ in thousands 777,270 744,065 709,177 629,405 662,321 602,462 604,284 566,427 586,662 559,003 566,704 617,548 683,739 638,305 618,871 577,022 580,096 534,666 513,187 483,663
Total asset turnover 0.72 0.73 0.76 0.86 0.81 0.90 0.89 0.93 0.87 0.89 0.86 0.77 0.68 0.71 0.71 0.71 0.69 0.76 0.80 0.88

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $558,514K ÷ $777,270K
= 0.72

Exponent Inc's total asset turnover ratio has shown fluctuations over the past few years. The ratio decreased from 0.88 as of March 31, 2020, to 0.72 as of December 31, 2024. This indicates that the company's ability to generate sales from its total assets has declined during this period.

The declining trend in the total asset turnover ratio may suggest inefficiencies in asset utilization or difficulties in generating revenue relative to the size of the asset base. A lower total asset turnover ratio could signify excess or underutilized assets within the company, poor sales performance, or inefficient asset management.

It would be crucial for Exponent Inc to analyze the factors contributing to the decreasing total asset turnover ratio to address any operational inefficiencies and improve overall performance. By enhancing asset utilization and streamlining operations, the company may be able to increase its total asset turnover ratio, leading to improved financial efficiency and profitability.


Peer comparison

Dec 31, 2024

Company name
Symbol
Total asset turnover
Exponent Inc
EXPO
0.72
FTI Consulting Inc
FCN
1.03
Genpact Limited
G
0.96